| Authors: |
Ichim TE; Immorta Bio Inc., Miami, FL, US. Thomas.ichim@gmail.com.; Immorta Bio Inc, San Diego, CA, US. Thomas.ichim@gmail.com., Markov N; Buck Institute for Research on Aging, Novato, CA, USA., Lopes G; Department of Medical Oncology, Miller School of Medicine, University of Miami, Miami, FL, US., Pascual KA; Immorta Bio Inc., Miami, FL, US., Evans A; Immorta Bio Inc., Miami, FL, US., Reznik R; Department of Radiation Oncology, Cedars Sinai, Los Angeles, CA, US., Bykoriz V; Immorta Bio Inc., Miami, FL, US., Fortunati CA; Immorta Bio Inc., Miami, FL, US., Minev B; Department of Radiation Oncology, University of California San Diego, San Diego, CA, US., Ramos RA; Immorta Bio Inc., Miami, FL, US., Bajnath A; Institute for Human Optimization, Hanover, MD, US.; Department of Medicine, George Washington University, Washington, DC, US., Lin E; BioCenturium LLC, San Diego, CA, US., Hu J; Translational and Advanced Medicine (TAM) Biosciences, Nashville, TN, USA., Marincola FM; Translational and Advanced Medicine (TAM) Biosciences, Nashville, TN, USA., Rath A; Immorta Bio Inc., Miami, FL, US., Barrett B; University of California, California, US., Jurow A; Mills-Peninsula Medical Center, Burlingame, CA, US., Sankhala KK; Department of Medical Oncology, Cedars Sinai, Los Angeles, CA, US., Furman D; Buck Institute for Research on Aging, Novato, CA, USA., Reznik BN; Immorta Bio Inc., Miami, FL, US. |
